威智医药股份有限公司 成立于2006，是一家以技术创新为依托， 研发，生产，销售 一体的医药公司。经历十几年的发展，从最初的手性硼烷产品的基础上不断延伸产业链，已形成硼烷产品，特色原料药和仿制药，改良新药CMC全产业链。

威智医药专注多步合成，能满足克级到吨级， 临床I到临床III 以及上市生产。

 到目前为止，已经开发和生产超过35种特色原料药和制剂，主要用于糖尿病、抗真菌、眼科、肿瘤、戒烟、核磁共振造影剂和心血管治疗领域。

Viwit Pharmaceuticals Limited (Viwit), founded in 2006, is a fast-growing research-based pharmaceutical company.

Viwit specializes in multi-step synthetic processes in batch sizes from grams to tons to support clinical trials from Phase I to Phase III to post-launch production.  

Viwit aims to shorten the lead time and lower the cost of new drug development.

Till now Viwit has already developed and manufactured more than 35 generic APIs and formulations, mainly in diabetes, anti-fungal, ophthalmic, oncology, smoking cessation, MRI contrast agent and cardiovascular therapeutic areas.